(¿Â¶óÀÎ) ´ëÇѾȰúÇÐȸ Á¦126ȸ Çмú´ëȸ ¹× Á¦2ȸ ¾Æ½Ã¾Æ.ÅÂÆò¾ç ¾È¿µ»óÇÐȸ Çмú´ëȸ(3ÀÏÂ÷) : 2021-10-31±³À°ÀÏÀÚ : 2021-10-31
±³À°Àå¼Ò : ¿Â¶óÀÎ(¿ÀÇÁ¶óÀÎ. ±×·£µå¿öÄ¿Èú¼¿ïÈ£ÅÚ)
±³À°ÁÖÁ¦ :
(¿Â¶óÀÎ) ´ëÇѾȰúÇÐȸ Á¦126ȸ Çмú´ëȸ ¹× Á¦2ȸ ¾Æ½Ã¾Æ.ÅÂÆò¾ç ¾È¿µ»óÇÐȸ Çмú´ëȸ(3ÀÏÂ÷)ÁÖÃÖ±â°ü : ´ëÇѾȰúÇÐȸ
´ã´çÀÚ : Àü¹Ì¼÷
¿¬¶ôó : 02-3487-8055
À̸ÞÀÏ :
kos@ophthalmology.org ±³À°Á¾·ù : ¾È°ú
Âü¼®¿¹»óÀοø : 2000¸í
Èñ¸ÁÆòÁ¡ : 5Á¡
Áö¿ª :
¼¿ïƯº°½Ã±³À°½Ã°£ : 6 ½Ã°£ 10ºÐ
¼¼ºÎ¼ö°·á : 120,000¿ø
ºñ°í Á¤È¸¿ø ȸºñ ¹Ì³³È¸¿ø / 3Àϵî·Ï 80,000¿ø / 3ÀÏ-´çÀϿ¶óÀεî·Ï 100,000¿ø /1Àϵî·Ï 60,000¿ø / 1ÀÏ-´çÀÏ ¿Â¶óÀεî·Ï 80,000¿øÁ¤È¸¿ø ȸºñ ³³ºÎȸ¿ø 3Àϵî·Ï 55,000¿ø / 3ÀÏ-´çÀÏ ¿Â¶óÀÎ 75,000¿ø / »çÀü-1Àϵî·Ï 40.000¿ø / 1ÀÏ-´çÀÏ ¿Â¶óÀÎ µî·Ï 60,000¿øÁØȸ¿ø ȸºñ ¹Ì³³È¸¿ø 3Àϵî·Ï 50,000¿ø / 3ÀÏ-´çÀϿ¶óÀÎ 70,000¿ø /»çÀü-1Àϵî·Ï 35,000¿ø / ´çÀÏ-1Àϵî·Ï 55,000¿ø - °ü°èÀÚ ¾È°úº´(ÀÇ)¿ø Á¾»çÀÚ(°£È£»çÆ÷ÇÔ), °ü·Ã¾÷ü Á¾»çÀÚ »çÀü-35,000¿ø/ ÇöÀå - 55,000¿ø Ÿ°ú ÀÇ»ç 3Àϵî·Ï »çÀü-100,000¿ø / ÇöÀå-120,000¿ø * ¿Â¶óÀÎ ¿¬¼ö±³À° ´ã´çÀÚ ·Î±×ÀÎ À̸ÞÀÏ
kma@kma.org ±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 10-31 walker hall 08:50~09:10 Are multifocal Intraocular Cataract Lenses currently evolving? ±è¸íÁØ(¸®´º¼¿ï¾È°ú)
±³À°½Ã°£ 10-31 walker hall 09:10~09:25 Treatment of strabismus, Beyond the limit ±è¼ºÁØ(¼¿ïÀÇ´ë)
±³À°½Ã°£ 10-31 walker hall 09:25~09:40 The role of neuroimaging in neuroophthalmolgy ±è´ëÇö(Á¶¼±ÀÇ´ë)
±³À°½Ã°£ 10-31 walker hall 09:40~09:55 Treatment of Pediatric lacrimal drainage system disease: You can do it! À̼ºº¹(Ãæ³²ÀÇ´ë)
±³À°½Ã°£ 10-31 walker hall 09:55~10:10 Clinical applications of Optical coherence tomography angiography À̹̿¬(°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 10-31 walker hall 10:10~10:25 New glaucoma medications À¯Á¤±Ç(°í·ÁÀÇ´ë)
±³À°½Ã°£ 10-31 walker hall 10:25~10:40 Optical coherence tomography/Optical coherence tomography angiography biomarker for the diagnosis and management of uveitis ¹èÁ¤ÈÆ(¼º±Õ°üÀÇ´ë °ºÏ»ï¼ºº´¿ø)
±³À°½Ã°£ 10-31 walker hall 10:40~10:55 Update on International Society for Clinical Electrophysiology of Vision standards ±èÈƵ¿(¼øõÇâÀÇ´ë)
±³À°½Ã°£ 10-31 walker hall 10:55~11:10 Diagnosis and treatment of meibomian gland dysfunction Ȳȣ½Ä(°¡Å縯ÀÇ´ë ¿©Àǵµ¼º¸ðº´¿ø)
±³À°½Ã°£ 10-31 walker hall 11:10~11:25 Considerations for Cataract Surgery in Eyes with Corneal Problems ³ª°æ¼±(°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 10-31 walker hall 11:25~11:40 Update on therapeutic contact lenses ÀÌÈÆ(¿ï»êÀÇ´ë)
Åä·Ð 10-31 walker hall 11:40~12:00 Discussion ()
ÈÞ½Ä 10-31 walker hall 12:00~13:00 break ()
±³À°½Ã°£ 10-31 walker hall 13:00~13:20 Pediatric eye care, MUST-KNOW tips ȲÁ¤¹Î(¼¿ïÀÇ´ë)
±³À°½Ã°£ 10-31 walker hall 13:20~13:28 Contact lens-related microbial keratitis ½Å¿µÁÖ(ÇѸ²ÀÇ´ë)
±³À°½Ã°£ 10-31 walker hall 13:28~13:36 Cataract Surgery with Pseudoexfoliation syndrome ±è¼ºÀç(°æ»óÀÇ´ë)
±³À°½Ã°£ 10-31 walker hall 13:36~13:44 Conjunctival chemosis ÃÖö¿µ(¼º±Õ°üÀÇ´ë °ºÏ»ï¼ºº´¿ø)
±³À°½Ã°£ 10-31 walker hall 13:44~13:52 Hands-on treatment of orbital wall fracture and enophthalmos »çÈ£¼®(¿ï»êÀÇ´ë)
±³À°½Ã°£ 10-31 walker hall 13:52~14:00 Seven Neuro-Ophthalmic Symptoms and Signs Not to be Missed ½ÅÇöÁø(°Ç±¹ÀÇ´ë)
±³À°½Ã°£ 10-31 walker hall 14:00~14:08 Approach to double vision ±èÇý¿µ(°Ç°º¸Çè°ø´Ü Àϻ꺴¿ø)
±³À°½Ã°£ 10-31 walker hall 14:08~14:16 When and what should we do for rapid glauocoma progressors? ¼º°æ¸²(¿ï»êÀÇ´ë)
±³À°½Ã°£ 10-31 walker hall 14:16~14:24 Differential diagnosis of various vitreous/retinal hemorrhages ±è»óÁø(¼º±Õ°üÀÇ´ë)
±³À°½Ã°£ 10-31 walker hall 14:24~14:32 Electrophysiologic tests for the differential diagnosis of malingering patients ±èÀÀ¼ö(±è¾È°úº´¿ø)
±³À°½Ã°£ 10-31 walker hall 14:32~14:40 Uveitis in the elderly ÀÌÁÖ¿ë(¿ï»êÀÇ´ë ¼¿ï¾Æ»êº´¿ø)
Åä·Ð 10-31 walker hall 14:40~15:00 Discussion ()
ÈÞ½Ä 10-31 walker hall 15:00~15:10 break ()
±³À°½Ã°£ 10-31 walker hall 15:10~15:30 Anterior Segment Examinations To be Performed Before Presbyopia-Correcting Cataract Surgery ±èÀç¿ë(¿ï»êÀÇ´ë)
Åä·Ð 10-31 walker hall 15:30~15:40 Discussion ()
±³À°½Ã°£ 10-31 walker hall 15:40~16:00 Interpretation of Parameters and Noticible Findings in Topography Before Corneal Refractive Surgery ±èÅ¿µ(¿¬¼¼ÀÇ´ë)
Åä·Ð 10-31 walker hall 16:00~16:10 Discussion ()